Changes in cannabis policy and prevalence of recreational cannabis use among adolescents and young adults in Europe—An interrupted time-series analysis

Abstract

Background Cannabis policy varies greatly across European countries, but evidence of how such policy impacts on recreational cannabis use among young people is conflicting. This study aimed to clarify this association by investigating how changes in cannabis legislation influenced cannabis use. Methods Available data on self-reports of recreational cannabis use among individuals aged 15–34 years was retrieved from EMCDDA. Information on cannabis policy changes was categorized as more lenient (decriminalisation or depenalisation) or stricter (criminalisation, penalisation). Countries that had implemented changes in cannabis legislation or had information on prevalence of use for at least eight calendar years, were eligible for inclusion. We used interrupted time-series linear models to investigate changes in country-specific trajectories of prevalence over calendar time and in relation to policy changes. Results Data from Belgium, Czech Republic, Germany, Italy, Netherlands, Norway, Portugal, Slovakia, Spain, Sweden and United Kingdom, for 1994–2017 was available for analyses. Cannabis use varied considerably over the study period and between countries. On average, use was stable or weakly increasing in countries where legislation was not changed or changed at the extremes of the study period (+0.08 percent per year [95% CI -0.01, 0.17 percent]). In contrast, the pooled average use decreased after changes in legislation, regardless of whether it had become more lenient (-0.22 [-1.21, 0.77]) or stricter (-0.44 [-0.91, 0.03]). Conclusions Our findings do not support any considerable impact of cannabis legislation on the prevalence of recreational cannabis use among youth and young adults in Europe.

Trends and Socio-Demographic Differences of Cannabis Vaping in the USA and Canada

“…It may be this common route of administration through inhalation of vaping products that has led young people who use cannabis to opt for vaping rather than smoking it. However, while the overall youth nicotine product use has been variable, trending up from 2017 to 2019 before trending down again between 2019 and 2021[ 40 ], the overall prevalence of cannabis use in young people from multiple countries has remained relatively stable even after medical and/or non-medical cannabis legalization [ 41 , 42 ]. Future research should collect information by delivery method and types of product use to inform preventative efforts.…”

Association between cannabis use and physical health problems in Norwegian adolescents: a cross-sectional study from the youth survey Ungdata

“…What is more, in Norway cannabis use is criminalized. Thus, assessing cannabis use within a school-survey may lead to an underreporting of the actual cannabis use prevalence, due to the fear of being identified and so punished for cannabis use [ 45 ]. Although the Ungdata survey is anonymous, this underreporting might be common especially in regions with small adolescent populations.…”

Use of Alcohol, Cannabinoids, Psychostimulants, and Sedatives before and during the COVID-19 Pandemic among Students in 40 European Countries

“…Although the highest DDDs were observed for European countries of the North (Sweden, Iceland, Norway) and the lowest mainly in those of the West (Netherlands, Austria, Germany), the prevalence of Central/Eastern European countries was visible in those located halfway up the list (Estonia, Czechia, Slovakia), compared to only one country of the South, i.e., Spain. As for cannabinoids, a study by Gabri et al efficiently summarizes cannabis use among adolescents and young adults [ 37 ]. The authors recapitulated the country-specific prevalence of self-reported cannabis use, within which three countries from Southern Europe (Spain, Italy, Portugal) and two from Central/Eastern Europe (Czechia, Slovakia) were included.…”